Home > Urology > EAU 2022

EAU 2022


European Association of Urology
01–04 July 2022
Amsterdam, the Netherlands

Table of Contents



Darolutamide performs well across subgroups in mHSPC

Presented By
Prof. Bertrand Tombal, Université Catholique de Louvain, Belgium

Genitourinary Cancer

Does systematic biopsy add value to the detection rate of prostate cancer?

Presented By
Dr Enrico Checcucci, University of Turin, Italy

PSMA PET/CT cannot replace mpMRI for diagnosis of prostate cancer

Presented By
Prof. Lih-Ming Wong, University of Melbourne, Australia

Prostate cancer treatments reduce quality of life

Presented By
Mr André Deschamps, Europa Uomo, Belgium

PROpel: Good results for abiraterone plus olaparib in mCRPC

Presented By
Prof. Noel Clarke, University of Manchester, UK

Neoadjuvant hormonal therapy promising in high-risk prostate cancer

Presented By
Prof. Steven Joniau, UZ Leuven, Belgium

Darolutamide performs well across subgroups in mHSPC

Presented By
Prof. Bertrand Tombal, Université Catholique de Louvain, Belgium

Shorter hospital stay with robotic surgery versus open surgery in bladder cancer

Presented By
Prof. James Catto, University of Sheffield, UK

Improved risk stratification for high-risk NMIBC

Presented By
Mr Florus de Jong, Erasmus University Medical Center, the Netherlands

Adjuvant atezolizumab may benefit ctDNA-positive patients with post-op muscle-invasive urothelial carcinoma

Presented By
Prof. Jürgen Gschwend, Technical University Munich, Germany

New prognostication in N3 penile cancer

Presented By
Dr James Churchill, St George Hospital, Australia

KEYNOTE-564: Updated results of adjuvant pembrolizumab in RCC

Presented By
Prof. Thomas Powles, Barts Cancer Institute, UK

Fewer complications with robotic surgery in renal cancer

Presented By
Prof. Marc-Oliver Grimm, Universitätsklinikum Jena, Germany

Functional Urology

Novel therapeutic targets for benign prostatic hyperplasia

Presented By
Prof. Richard Bryant, University of Oxford, UK

Mini-slings non-inferior to standard mid-urethral slings in SUI

Presented By
Prof. Mohamed Abdel-fattah, University of Aberdeen, UK

Non-inferiority of methenamine hippurate to antibiotics in recurrent UTIs

Presented By
Prof. Christopher Harding, Newcastle University, UK
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com